Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis

J R Wade1, S L Beal, N C Sambol

  • 1Department of Pharmacy, University of California, San Francisco 94143-0446.

Journal of Pharmacokinetics and Biopharmaceutics
|April 1, 1994
PubMed
Summary

The choice of pharmacokinetic model significantly impacts covariate analysis. Findings show that structural and covariate models are intertwined, influencing population pharmacokinetic model building.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.

Clinical pharmacology and therapeutics·2015
Same author

Assessment of Maraviroc Exposure-Response Relationship at 48 Weeks in Treatment-Experienced HIV-1-Infected Patients in the MOTIVATE Studies.

CPT: pharmacometrics & systems pharmacology·2013
Same author

CYP2A6 genotype but not age determines cotinine half-life in infants and children.

Clinical pharmacology and therapeutics·2013
Same author

Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse-transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients.

Clinical pharmacology and therapeutics·2010
Same author

Ways to fit a PK model with some data below the quantification limit.

Journal of pharmacokinetics and pharmacodynamics·2002
Same author

Nonlinearity detection: advantages of nonlinear mixed-effects modeling.

AAPS pharmSci·2001

Area of Science:

  • Pharmacometrics
  • Pharmacokinetics
  • Statistical Modeling

Background:

  • Population pharmacokinetic (Pop-PK) analysis is crucial for understanding drug disposition.
  • Model selection, including structural and covariate models, influences Pop-PK outcomes.
  • The interplay between structural and covariate model choices requires careful consideration.

Purpose of the Study:

  • To investigate how the selection of a pharmacokinetic model influences the identification of covariate relationships.
  • To examine the interdependence between structural and covariate model choices in Pop-PK analysis.

Main Methods:

  • Utilized simulated and real pharmacokinetic data sets.
  • Employed the NONMEM software for simulations and data analysis.
  • Evaluated model selection based on objective function values and covariate model complexity.

Related Experiment Videos

Main Results:

  • Simulated data initially favored a two-compartment model, but this preference diminished with increased one-compartment model complexity.
  • Real data analysis revealed that one-compartment models supported more complex covariate relationships than two-compartment models.
  • Demonstrated a significant intertwining between structural and covariate model selection processes.

Conclusions:

  • The selection of a pharmacokinetic structural model is influenced by the complexity of the covariate model.
  • The choice of covariate model is similarly affected by the chosen structural model.
  • Provides guidance for building robust population pharmacokinetic models by acknowledging this interdependence.